Cardiovascular · PANCE / PANRE

Atrioventricular (AV) Blocks

Delay or failure of AV nodal or infranodal conduction — first-degree, Mobitz I/II, third-degree (complete).

Also known as: AV block, heart block, first-degree AV block, Mobitz I, Wenckebach, Mobitz II, third-degree heart block, complete heart block

Overview

Disorders of conduction between atria and ventricles. First-degree: PR >200 ms with 1:1 conduction. Second-degree Mobitz I (Wenckebach): progressive PR prolongation until a non-conducted P wave. Mobitz II: constant PR with intermittent dropped beats. Third-degree (complete): AV dissociation with independent atrial and ventricular rates.

Epidemiology

Prevalence rises sharply with age and structural heart disease. Mobitz II and third-degree blocks reflect infranodal disease and are far more likely to progress to symptomatic or fatal bradycardia than nodal blocks.

Try two board-style Atrioventricular (AV) Blocks questions

Real questions from the FirstPassPA bank, with the full explanation. Pick an answer — no signup, no email.

Question 1CardiovascularEasy
A 78-year-old man reports one week of fatigue and several episodes of near-syncope. He takes no AV-nodal blocking medications. He is alert but ill-appearing; blood pressure is 96/58 mm Hg and the pulse is slow and regular at 34/min. A 12-lead ECG shows P waves marching out at 80/min completely independent of the QRS complexes, with a regular wide-complex escape rhythm at 34/min. Which of the following is the most appropriate definitive treatment?
  • APermanent pacemaker
  • BIntravenous atropine
  • CIsoproterenol infusion
  • DTranscutaneous pacing
Reveal answer & full explanation
Correct answer: A — Permanent pacemaker
  • APermanent pacemaker
  • BIntravenous atropine
  • CIsoproterenol infusion
  • DTranscutaneous pacing

Why Permanent pacemaker is correct

  • Atrioventricular dissociation (independent P waves at 80/min and a slower regular escape at 34/min) with symptoms (near-syncope, hypotension) is symptomatic complete (third-degree) AV block.
  • A permanent pacemaker is the only definitive therapy that restores reliable AV synchrony; symptomatic acquired third-degree block is a Class I pacing indication (per ACC/AHA/HRS bradycardia guidance).
  • Pharmacologic and external-pacing measures may stabilize the patient transiently but do not provide durable rhythm support.

Why the others are wrong

  • Intravenous atropine — a temporizing vagolytic that acts at the AV node and is typically ineffective in infranodal/complete block with a wide escape rhythm. Trap: premature closure on the reflexive ACLS bradycardia drug.
  • Isoproterenol infusion — a temporizing beta-agonist used to raise the escape rate; it is pro-arrhythmic and not definitive. Trap: right-diagnosis-wrong-step.
  • Transcutaneous pacing — an emergent bridge to definitive device therapy, not the definitive treatment itself. Trap: confusing the bridge with the destination.
Question 2CardiovascularEasy
A 72-year-old man has an ECG showing no relationship between P waves and QRS complexes. The atrial rate is 78 bpm and the ventricular rate is 38 bpm with wide QRS complexes. He is dizzy and his BP is 82/54. What is the immediate treatment?
  • ATranscutaneous pacing
  • BUrgent transvenous pacemaker placement
  • CIV atropine 1 mg
  • DIV calcium chloride
Reveal answer & full explanation
Correct answer: A — Transcutaneous pacing
  • ATranscutaneous pacing
  • BUrgent transvenous pacemaker placement
  • CIV atropine 1 mg
  • DIV calcium chloride

Why transcutaneous pacing is correct

  • This ECG shows complete (third-degree) atrioventricular (AV) block: no relationship between P waves and QRS complexes, atrial rate 78 bpm, ventricular rate 38 bpm with wide QRS complexes.
  • The patient is hemodynamically unstable (BP 82/54, dizzy), requiring immediate transcutaneous pacing to restore an adequate ventricular rate.
  • The wide-complex pattern suggests a ventricular escape rhythm at the level of the His-Purkinje system, which is less likely to respond to atropine (atropine may be tried first only in narrow-complex complete heart block with a junctional escape).
  • Definitive treatment is transvenous temporary pacing followed by permanent pacemaker implantation.

Why the others are wrong

  • Urgent transvenous pacemaker placement — the correct next step after stabilization, but line placement and positioning take time that a patient hypotensive now does not have; transcutaneous pacing is the bridge to it.
  • IV atropine 1 mg — may be tried in narrow-complex complete heart block, but this wide-complex ventricular escape rhythm is unlikely to respond; transcutaneous pacing takes priority in the unstable patient.
  • IV calcium chloride — reserved for bradycardia from hyperkalemia or calcium channel blocker toxicity; neither is suggested here, and it does not raise the rate in infranodal AV block.
🔒 Free preview limit reached

Keep reading — start your free trial

You've read your 2 free diagnosis previews. Create your free account to unlock the full Atrioventricular (AV) Blocks outline — plus all 514 diagnoses, 6,500+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.

Free to start · No credit card · Cancel anytime

Risk factors

  • Age-related conduction system degeneration (Lev and Lenègre disease)
  • Ischemic heart disease, especially inferior MI (transient AV nodal block) and anterior MI (infranodal block)
  • Medications: beta-blockers, non-dihydropyridine CCBs (diltiazem, verapamil), digoxin, amiodarone, ivabradine, clonidine
  • Increased vagal tone (athletes, sleep, carotid sinus hypersensitivity)
  • Cardiomyopathies and infiltrative diseases: amyloidosis, sarcoidosis, hemochromatosis
  • Lyme carditis, endocarditis with abscess, rheumatic fever
  • Iatrogenic: post-cardiac surgery (especially aortic/mitral surgery, TAVR), catheter ablation
  • Congenital complete heart block (maternal anti-Ro/SSA antibodies)

Pathophysiology

Conduction can fail in the AV node (typically Wenckebach — vagal influence, drug effect, ischemia from RCA territory) or in the His-Purkinje system below (Mobitz II and most complete blocks — fibrotic or ischemic). Nodal blocks are usually benign and responsive to atropine; infranodal blocks generally are not.

Clinical presentation

Symptoms

  • First-degree and Mobitz I: usually asymptomatic, incidental finding
  • Mobitz II and third-degree: fatigue, dyspnea, presyncope, syncope (Stokes-Adams attack), heart failure, angina
  • Worsening with negative chronotropic medications

Signs / physical exam

  • Bradycardia
  • Cannon A waves in third-degree block (atrial contraction against closed tricuspid valve)
  • Variable S1 intensity in third-degree block (AV dissociation)
  • Wide pulse pressure in complete heart block (large stroke volume)
  • Signs of heart failure in chronic high-grade block

Differential diagnosis

  • Sinus bradycardia — Slow but 1:1 conduction with normal PR; no dropped beats
  • Blocked premature atrial complex — Non-conducted P wave but P morphology differs from sinus and timing is premature
  • Vagally mediated AV block — Often nocturnal, asymptomatic, athletes; responds to exercise; benign
  • Junctional escape rhythm — Narrow QRS 40-60 bpm with no P or inverted retrograde P; backup rhythm in sinus arrest or complete block
  • Ventricular escape rhythm — Wide QRS 20-40 bpm; backup in complete heart block with infranodal disease
  • Atrial fibrillation with regularized slow ventricular rate — Suggests complete AV block with junctional/ventricular escape

Diagnostic workup

Diagnostic criteria

First-degree: PR interval >200 ms with each P followed by a QRS. Mobitz I: progressive PR prolongation, then a single dropped QRS; cycle repeats. Mobitz II: constant PR, sudden dropped QRS without prior PR change. Third-degree: complete AV dissociation, atrial rate exceeds ventricular rate, ventricular escape rhythm (junctional 40-60 narrow, or ventricular 20-40 wide).

Labs

  • BMP, magnesium, calcium, TSH
  • Troponin if ischemic etiology suspected
  • Digoxin level if applicable
  • Lyme serology, sarcoidosis workup in selected patients

Imaging

  • 12-lead ECG — diagnostic; characterize PR and AV relationship
  • Holter or event monitor for intermittent block
  • Echocardiogram — assess structural heart disease, valvular abnormalities
  • Cardiac MRI/PET if infiltrative cardiomyopathy or sarcoidosis suspected

Diagnostic algorithm

TypeECG featuresSiteSymptoms / riskPacing indication
First-degreePR >200 ms, every P conductedUsually AV nodeAsymptomaticNot indicated
Mobitz I (Wenckebach)Progressive PR lengthening, then dropped QRSAV nodeUsually asymptomaticOnly if symptomatic
Mobitz IIConstant PR, sudden dropped QRSInfranodal (His-Purkinje)Syncope; high progression riskYes — Class I
High-grade (2:1 or worse)≥2 consecutive blocked P wavesVariableBradycardia, syncopeUsually yes
Third-degree (complete)AV dissociation; atrial rate > ventricular escapeAnywhere; usually infranodalSyncope, sudden deathYes — Class I
Classification of AV blocks with implications for pacing.

Treatment

First-line

  • Identify and remove reversible causes: hold AV nodal blockers, correct electrolytes, treat ischemia, treat Lyme
  • Asymptomatic first-degree and Mobitz I (with narrow QRS): no specific therapy, observation
  • Symptomatic bradycardia: atropine 0.5-1 mg IV q3-5 min up to 3 mg total (effective for nodal blocks, less so for infranodal)
  • Transcutaneous pacing for unstable symptomatic block as bridge to transvenous pacing
  • Dopamine 5-20 mcg/kg/min or epinephrine 2-10 mcg/min as alternatives if atropine fails

Second-line / adjunct

  • Permanent pacemaker (Class I) for: symptomatic Mobitz I or Mobitz II, any third-degree AV block (symptomatic or asymptomatic with significant escape pauses), advanced second-degree block
  • Permanent pacemaker (Class IIa) for: asymptomatic Mobitz II, asymptomatic high-grade block with average HR <40, alternating bundle branch block
  • Dual-chamber pacing preferred over single-chamber for sinus rhythm with intact atrial activity
  • Avoid permanent pacing for reversible causes (drug effect, electrolyte, Lyme — most resolve with treatment)
  • Cardiac resynchronization therapy if EF ≤35% and significant ventricular pacing burden expected

Complications

  • Syncope with injury (Stokes-Adams attack)
  • Sudden cardiac death from asystole or ventricular escape failure
  • Heart failure from chronic bradycardia and AV dyssynchrony
  • Pacemaker complications: lead displacement, infection, RV pacing-induced cardiomyopathy
  • Tachy-brady syndrome (sick sinus) — pause-dependent symptoms

PANCE pearls

  • Mobitz I (Wenckebach) with NARROW QRS is usually nodal and benign; Mobitz II is infranodal and warrants a pacemaker.
  • Atropine is effective for AV nodal blocks but may paradoxically worsen infranodal blocks by speeding atrial rate without improving conduction.
  • Inferior MI causes transient AV nodal block (RCA supplies AV node in ~90%) — usually resolves; rarely needs permanent pacing.
  • Anterior MI with new AV block reflects extensive infranodal damage and carries high mortality — often needs pacing.
  • Always check for reversible causes (drugs, Lyme, electrolytes) before committing a patient to a permanent pacemaker.

Images

First-degree AV block — PR interval prolonged >200 ms, every P wave conducted
First-degree AV block — PR interval prolonged >200 ms, every P wave conducted
Mobitz I (Wenckebach) — progressive PR prolongation until a dropped beat
Mobitz I (Wenckebach) — progressive PR prolongation until a dropped beat
Mobitz II — fixed PR interval with intermittent non-conducted P waves; high risk of progression
Mobitz II — fixed PR interval with intermittent non-conducted P waves; high risk of progression
Third-degree (complete) AV block — AV dissociation; atrial and ventricular rates independent
Third-degree (complete) AV block — AV dissociation; atrial and ventricular rates independent

References

  • ACC/AHA/HRS 2018 Bradycardia — 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay (Kusumoto et al., Circulation 2019)
  • ESC 2021 Pacing — 2021 ESC Guidelines on Cardiac Pacing and Cardiac Resynchronization Therapy (Glikson et al., Eur Heart J 2021)

Practice Cardiovascular questions on FirstPassPA

Turn this outline into retention. 6,500+ board-style questions with an AI tutor that explains every answer — free to start, no card required.

Answer the 2 free questions above → Get today's free question →

Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA or PAEA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants; End of Rotation™ is a program of the Physician Assistant Education Association.